Search results for "Th17"

showing 7 items of 97 documents

Modulation of TH1/TH17 equilibrium in vitro by indicaxanthin from Opuntia ficus indica (L. Mill)

2012

Indicaxanthin, Th1

chemistry.chemical_compoundchemistrySettore BIO/10 - BiochimicaPhysiology (medical)Opuntia ficusBotanyIndicaxanthin phytochemical Th1Th1 th17BiologyBiochemistryIndicaxanthinIn vitroFree Radical Biology and Medicine
researchProduct

Human Memory Th17 Cell Populations Change Into Anti-inflammatory Cells With Regulatory Capacity Upon Exposure to Active Vitamin D

2019

Autoimmune diseases are characterized by an aberrantly activated immune system, resulting in tissue damage and functional disability in patients. An important therapeutic goal is to restore the deregulated immunological balance between pro- A nd anti-inflammatory T cells. This imbalance is illustrated by elevated levels and activity of memory Th17 cell populations, such as Th17, Th1/Th17, and Th17.1 cells, in various autoimmune diseases. These cells are characterized by the chemokine receptor CCR6, RORC expression and production of IL-17A, IFNγ, and TNFα. Using rheumatoid arthritis (RA) as a model of autoimmune disease, we here demonstrate that pro-inflammatory memory CCR6+ Th cells can swi…

lcsh:Immunologic diseases. Allergy0301 basic medicineAdultMaleReceptors CCR6rheumatoid arthritisCD3 ComplexCD3CellImmunologyAnti-Inflammatory Agentschemical and pharmacologic phenomenavitamin DC-C chemokine receptor type 6Autoimmune DiseasesArthritis Rheumatoid03 medical and health sciencesChemokine receptor0302 clinical medicineImmune systemsynovial fluidRAR-related orphan receptor gammamedicineImmunology and AllergyHumansCells CulturedOriginal ResearchAutoimmune diseasebiologyChemistryTumor Necrosis Factor-alphaInterleukinsMiddle Agedmedicine.diseaseTreg030104 developmental biologymedicine.anatomical_structureImmunologybiology.proteinTh17 CellsTumor necrosis factor alphaFemaleTh17lcsh:RC581-607Immunologic Memory030215 immunologyFrontiers in Immunology
researchProduct

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview

2021

Interleukin-23 (IL-23) is a pro-inflammatory cytokine composed of two subunits, IL-23A (p19) and IL-12/23B (p40), the latter shared with Interleukin-12 (IL-12). IL-23 is mainly produced by macrophages and dendritic cells, in response to exogenous or endogenous signals, and drives the differentiation and activation of T helper 17 (Th17) cells with subsequent production of IL-17A, IL-17F, IL-6, IL-22, and tumor necrosis factor α (TNF-α). Although IL-23 plays a pivotal role in the protective immune response to bacterial and fungal infections, its dysregulation has been shown to exacerbate chronic immune-mediated inflammation. Well-established experimental data support the concept that IL-23/IL…

lcsh:Immunologic diseases. Allergy0301 basic medicinemedicine.medical_treatmentImmunologyinflammatory diseasesInflammationautoimmune diseaseAutoimmunityReviewInflammatory bowel diseaseInterleukin-23Th17 CellRheumatic Disease03 medical and health sciencesPsoriatic arthritis0302 clinical medicineImmune systemIL-23PsoriasisRheumatic DiseasesInterleukin 23medicineAnimalsHumansImmunology and Allergyautoimmune diseasesMolecular Targeted TherapyIL-23/IL-17 axi030203 arthritis & rheumatologyInflammationbusiness.industryIL-23/IL-17 axisAnimalInterleukin-17medicine.diseaseinflammatory diseaseIL-17030104 developmental biologyCytokineImmunologyTh17 CellsInterleukin 17medicine.symptomlcsh:RC581-607businessHuman
researchProduct

Treg activation status depends on psoriasis therapy regime

2020

medicine.medical_specialtybusiness.industryPsoriasismedicineMEDLINEHumansPsoriasisTh17 CellsDermatologymedicine.diseasebusinessT-Lymphocytes RegulatoryDermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Dendritic Cell-Specific Deletion of β-Catenin Results in Fewer Regulatory T-Cells without Exacerbating Autoimmune Collagen-Induced Arthritis.

2015

Dendritic cells (DCs) are professional antigen presenting cells that have the dual ability to stimulate immunity and maintain tolerance. However, the signalling pathways mediating tolerogenic DC function in vivo remain largely unknown. The beta-catenin pathway has been suggested to promote a regulatory DC phenotype. The aim of this study was to unravel the role of beta-catenin signalling to control DC function in the autoimmune collagen-induced arthritis model (CIA). Deletion of beta-catenin specifically in DCs was achieved by crossing conditional knockout mice with a CD11c-Cre transgenic mouse line. Bone marrow-derived DCs (BMDCs) were generated and used to study the maturation profile of …

medicine.medical_treatmentT cellAntigen-Presenting Cellslcsh:Medicinechemical and pharmacologic phenomenaBiologyT-Lymphocytes RegulatoryImmune toleranceMiceImmune TolerancemedicineAnimalsHumansCytotoxic T cellAntigen-presenting celllcsh:ScienceCollagen Type IIbeta CateninMice KnockoutMultidisciplinarylcsh:Rhemic and immune systemsDendritic CellsDendritic cellArthritis ExperimentalToll-Like Receptor 2Toll-Like Receptor 4TLR2Cytokinemedicine.anatomical_structureImmunologyTh17 Cellslcsh:QCD8Research ArticleSignal TransductionPLoS ONE
researchProduct

Phenotypic and genetic characterization of emerging trematodiasis: Fascioliasis and Schistosomiasis

2021

La Fascioliasis y la Esquistosomiasis son dos importantes trematodiasis (re)emergentes con gran impacto en la salud humana. Dada la necesidad de caracterizar las poblaciones de Trematodos involucradas, los objetivos de la presente investigación son: en primer lugar, analizar el impacto de la reinfección experimental por Fasciola hepatica en los fenotipos inmunológicos, clínicos y biológicos por medio de un diseño experimental que reproduce las condiciones habituales de reinfección/cronicidad en las zonas endémicas de la Fascioliasis humana; en segundo lugar, la caracterización fenotípica morfológica de huevos de Schistosoma haematobium de migrantes subsaharianos con Esquistosomiasis urogeni…

migrantsbovisreinfectionTh1CIASTh2sheddingepgmorphologyspainhaematobiumPCACVAmorphometricsIgG1hepaticaemergingfasciolamansoni:CIENCIAS MÉDICAS [UNESCO]anemiacytokinescox1TregUNESCO::CIENCIAS MÉDICASschistosomaeggTh17ITSmorphometry
researchProduct

Pathogenesis of polymyalgia rheumatica

2018

Polymyalgia rheumatica (PMR) is a chronic, inflammatory disorder of unknown cause, almost exclusively occurring in people aged over 50 and often associated with giant cell arteritis. The evidence that PMR occurs almost exclusively in individuals aged over 50 may indicate that age-related immune alterations in genetically predisposed subjects contribute to development of the disease. Several infectious agents have been investigated as possible triggers of PMR even though the results are inconclusive. Activation of the innate and adaptive immune systems has been proved in PMR patients as demonstrated by the activation of dendritic cells and monocytes/macrophages and the altered balance betwee…

musculoskeletal diseaseslcsh:Internal medicineGiant Cell ArteritisAdaptive immunityeducationlcsh:MedicineDiseaseT-Lymphocytes RegulatoryPathogenesisPolymyalgia rheumatica03 medical and health sciences0302 clinical medicineImmune systemRheumatologyPathogenesiHumansMedicinelcsh:RC31-1245Giant Cell ArteritiB cellAgedInnate immunity030203 arthritis & rheumatologyB-LymphocytesEvidence-Based MedicineInnate immune systembusiness.industrylcsh:RPolymyalgia rheumaticaB-LymphocyteCell DifferentiationBiomarkerPathogenesis.medicine.diseaseAcquired immune systemImmunity InnateSettore MED/16 - ReumatologiaGiant cell arteritismedicine.anatomical_structure030220 oncology & carcinogenesisImmunologyTh17 CellsbusinessBiomarkersHumanReumatismo
researchProduct